Microchip Technology Incorporated (MCHP), the Chandler, Arizona–based designer of microcontrollers, analog semiconductors, and embedded control solutions, has just absorbed a sharp post-earnings selloff. The question now facing investors is whether the stock can rebuild toward the average analyst price target of roughly $90.
The $90 central target is not a published consensus; it is an average calculated from current, attributable analyst targets. Reviewing roughly a dozen individual price targets issued in recent months — most revised after the company's most recent quarterly report — the figures cluster between $62 (Truist, Hold) and $120 (KeyBanc, Buy), with a few older Street-highs near $135. The arithmetic mean of the current set is approximately $91, rounded to a clean $90.
Views differ sharply. The cautious end includes Truist at $62, Wells Fargo at $70, and Citi at $75 (Buy). The middle is anchored by Raymond James at $80, with UBS, Jefferies, and Needham each at $85. More bullish targets include Cantor Fitzgerald and J.P. Morgan at $100, Rosenblatt at $115, Evercore ISI at $117, and KeyBanc at $120.
Post-earnings revisions were almost entirely downward. Raymond James cut its target to $80 from $125, Jefferies to $85 from $100, UBS to $85 from $105, Needham to $85 from $120, and Cantor Fitzgerald to $100 from $125. Analysts cited lower earnings expectations, margin resets, and reduced market multiples, even as most kept Buy or Overweight ratings.
At a closing price of $58.35, MCHP would need to rise roughly 54% to reach $90. That is a very large move, implying the stock must reverse a steep downturn: shares fell about 10% in a single session after the company reported quarterly results that beat expectations but issued guidance with a midpoint below estimates.
The path is tied to the semiconductor cycle. Microchip's revenue collapsed from a peak of $8.44 billion in fiscal 2023 to $4.40 billion in fiscal 2025 as customers worked through excess inventory. Fiscal 2026 revenue of $4.71 billion marked the turn, and analysts project roughly $6.4 billion in fiscal 2027. If that recovery holds and margins normalize, the current valuation could expand.
The sharp single-session decline leaves MCHP below the round-number $60 level, which may now act as a near-term psychological reference point. Because the stock fell through a broad trading range on elevated volume, any recovery toward $90 would require reclaiming that zone and sustaining momentum; no verified long-term support or resistance level should be assumed beyond these observations.
Analyst price targets typically reflect a roughly 12-month research horizon, though individual analysts differ. Investors should watch upcoming quarterly results and guidance, analyst target revisions, inventory and booking trends across the semiconductor supply chain, margin recovery, and interest-rate and macroeconomic signals that influence cyclical chip demand.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from changing market conditions, technical behavior, and AI-driven analysis. Traders can use the tool to discover opportunities, monitor existing positions, and spot changing trends more efficiently than manual screening allows. For investors tracking volatile names such as MCHP, AI Daily Buy/Sell Signals can serve as a data-driven complement to traditional research.
Whether MCHP can reach $90 depends on the durability of the semiconductor recovery and on margins stabilizing faster than the market currently expects. The $90 figure — the rounded average of current analyst targets — implies roughly 54% upside, a very large move that would require the stock to reclaim ground lost in its post-earnings selloff. Supportive factors include recovering bookings, an expanding backlog, and strong projected EPS growth, while the principal obstacles are below-estimate guidance, margin pressure, supply constraints, and a wide, visibly cautious analyst range. With targets spanning $62 to $120, there is no consensus on timing; investors should monitor quarterly guidance and demand signals before drawing conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, MCHP has been closely correlated with MCHPP. These tickers have moved in lockstep 99% of the time. This A.I.-generated data suggests there is a high statistical probability that if MCHP jumps, then MCHPP could also see price increases.
| Ticker / NAME | Correlation To MCHP | 1D Price Change % | ||
|---|---|---|---|---|
| MCHP | 100% | -0.64% | ||
| MCHPP - MCHP | 99% Closely correlated | -0.75% | ||
| TXN - MCHP | 81% Closely correlated | -2.84% | ||
| ADI - MCHP | 80% Closely correlated | -2.77% | ||
| NXPI - MCHP | 77% Closely correlated | -0.82% | ||
| ON - MCHP | 76% Closely correlated | -3.62% | ||
More | ||||